Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$107.45 +0.9%	$103.02	$71.88 ▼ $108.57	$157.61B	0.68	6.60 million shs	7.01 million shs
CCL Carnival	$28.15 +3.3%	$22.46	$13.78 ▼ $28.72	$31.82B	2.58	25.11 million shs	32.21 million shs
FLR Fluor	$51.31 -0.2%	$41.88	$29.20 ▼ $60.10	$8.47B	1.3	2.62 million shs	1.94 million shs
LMNX Luminex	$36.99	$36.90	$20.61 ▼ $41.69	$1.75B	0.56	873,093 shs	N/A

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	+0.58%	+4.95%	+2.26%	+6.17%	+39.53%
CCL Carnival	+3.06%	+16.90%	+21.18%	+45.29%	+50.37%
FLR Fluor	-0.44%	+4.23%	+23.37%	+41.19%	+17.82%
LMNX Luminex	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSX Boston Scientific	4.1498 of 5 stars	2.6	3.0	0.0	4.2	2.6	2.5	1.3
CCL Carnival	4.7012 of 5 stars	2.3	3.0	0.0	3.1	3.2	1.7	4.4
FLR Fluor	4.0111 of 5 stars	2.3	2.0	0.0	1.3	2.7	2.5	3.1
LMNX Luminex	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	3.13	Buy	$116.09	8.04% Upside
CCL Carnival	2.60	Moderate Buy	$28.53	1.35% Upside
FLR Fluor	2.63	Moderate Buy	$47.14	-8.12% Downside
LMNX Luminex	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CCL, LMNX, BSX, and FLR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/26/2025	CCL Carnival	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$21.00 ➝ $24.00
6/25/2025	CCL Carnival	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$33.00 ➝ $35.00
6/25/2025	CCL Carnival	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$33.00 ➝ $34.00
6/25/2025	CCL Carnival	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Positive ➝ Positive	$27.00 ➝ $30.00
6/25/2025	CCL Carnival	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$30.00 ➝ $31.00
6/25/2025	CCL Carnival	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$30.00 ➝ $33.00
6/24/2025	FLR Fluor	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$48.00 ➝ $60.00
6/23/2025	CCL Carnival	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$33.00 ➝ $34.00
6/23/2025	CCL Carnival	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$27.00
6/23/2025	CCL Carnival	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
6/23/2025	CCL Carnival	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$22.00

(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$16.75B	9.49	$3.68 per share	29.18	$14.93 per share	7.20
CCL Carnival	$25.02B	1.31	$4.10 per share	6.86	$8.02 per share	3.51
FLR Fluor	$16.32B	0.52	$2.78 per share	18.45	$23.27 per share	2.20
LMNX Luminex	$417.40M	4.19	$1.12 per share	32.98	$11.13 per share	3.32

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$1.85B	$1.37	78.43	33.27	2.75	11.58%	18.67%	10.38%	7/23/2025 (Estimated)
CCL Carnival	$1.92B	$1.50	15.22	13.47	0.60	9.72%	27.88%	5.20%	N/A
FLR Fluor	$2.15B	$10.43	4.92	17.63	2.47	11.13%	14.59%	5.67%	8/1/2025 (Estimated)
LMNX Luminex	$15.17M	$0.32	72.53	30.83	N/A	5.39%	4.66%	2.91%	N/A

Latest CCL, LMNX, BSX, and FLR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/23/2025	Q2 2025	BSX Boston Scientific	$0.72	N/A	N/A	N/A	$4.89 billion	N/A
6/24/2025	Q2 2025	CCL Carnival	$0.24	$0.35	+$0.11	$0.42	$6.20 billion	$6.33 billion
5/2/2025	Q1 2025	FLR Fluor	$0.50	$0.73	+$0.23	-$1.42	$4.27 billion	$3.98 billion
4/23/2025	Q1 2025	BSX Boston Scientific	$0.67	$0.75	+$0.08	$0.45	$4.57 billion	$4.66 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
CCL Carnival	N/A	N/A	N/A	N/A	N/A
FLR Fluor	N/A	N/A	N/A	N/A	N/A
LMNX Luminex	$0.40	1.08%	N/A	125.00%	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.47	1.45	0.88
CCL Carnival	2.58	0.34	0.30
FLR Fluor	0.30	1.74	1.74
LMNX Luminex	0.52	8.37	6.08

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
CCL Carnival	67.19%
FLR Fluor	88.07%
LMNX Luminex	87.76%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.50%
CCL Carnival	7.60%
FLR Fluor	1.70%
LMNX Luminex	6.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	53,000	1.48 billion	1.47 billion	Optionable
CCL Carnival	100,000	1.17 billion	1.08 billion	Optionable
FLR Fluor	26,866	164.66 million	161.87 million	Optionable
LMNX Luminex	1,325	47.31 million	N/A	Optionable

CCL, LMNX, BSX, and FLR Headlines

Recent News About These Companies

Luminex PLC gets contract to increase capacity of public water treatment plant in Horana EPZ

December 11, 2024 | ft.lkF

ProCap is Proud to Announce the Planning Launch of the Luminex Payment Gateway

November 14, 2024 | markets.businessinsider.com

Luminex gets cleaning project of Kankasanthurei cement factory

August 6, 2024 | ft.lkF

Luminex wins bid to clean up Kankasanthurei cement factory complex

August 6, 2024 | dailymirror.lkD

ERS electronic GmbH: ERS electronic releases fully automatic Luminex machines with PhotoThermal debonding and wafer cleaning capability

May 29, 2024 | finanznachrichten.de

ERS electronic releases fully automatic Luminex machines with PhotoThermal debonding and wafer cleaning capability

May 29, 2024 | asiaone.comA

Flash News: OKX Wallet Web Extension Expands to Include Luminex Access

April 18, 2024 | finance.yahoo.com

Luminex-Puritas JV secures Mallavi Urban Water Supply Scheme contract in Mullaitivu

March 24, 2024 | ft.lkF

ERS electronic introduces the first semi-automatic machine of its Luminex product line featuring groundbreaking PhotoThermal debonding technology

March 13, 2024 | finance.yahoo.com

Adventus and Luminex Announce Merger to Create a Growth-Focused Copper-Gold Company in Ecuador

November 21, 2023 | finance.yahoo.com

Luminex Resources Corp (LR)

October 28, 2023 | investing.com

Luminex Resources Announces Excellent Metallurgical Results at Cuyes West

September 27, 2023 | juniorminingnetwork.com

Luminex Announces Excellent Metallurgical Results at Cuyes West

September 27, 2023 | newswire.ca

Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance

September 25, 2023 | 360dx.com3

Luminex (LMNX) Receives FDA Approval for NxTAG RPP

September 24, 2023 | finance.yahoo.com

Luminex Has Entered into Discussions with Anglo American to Amend the Terms of the Pegasus Earn-In

September 20, 2023 | prnewswire.com

Luminex Reaches Agreement with a Second Association of Artisanal Miners Around Condor North

September 8, 2023 | finance.yahoo.com

Stenograph Announces the Release of the Bordeaux Luminex II

September 6, 2023 | marketscale.comM

Luminex moots JV with Puritas

September 5, 2023 | ft.lkF

Luminex Announces an Update on the Pegasus Earn-in

August 23, 2023 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CCL, LMNX, BSX, and FLR Company Descriptions

Boston Scientific NYSE:BSX

$107.45 +0.92 (+0.86%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$107.58 +0.13 (+0.12%)

As of 08:59 AM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Carnival NYSE:CCL

$28.15 +0.89 (+3.26%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$27.90 -0.25 (-0.90%)

As of 09:04 AM Eastern

Carnival Corp. engages in the operation of cruise ships. It operates through the following business segments: North America and Australia (NAA) Cruise, Europe and Asia (EA) Cruise Operations, Cruise Support, and Tour and Others. The North America and Australia (NAA) Cruise segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe and Asia (EA) Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Fluor NYSE:FLR

$51.31 -0.11 (-0.21%)

Closing price 06/30/2025 03:58 PM Eastern

Extended Trading

$51.22 -0.09 (-0.17%)

As of 08:55 AM Eastern

Fluor Corporation provides engineering, procurement, and construction (EPC); fabrication and modularization; operation and maintenance; asset integrity; and project management services worldwide. The company operates through Energy Solutions, Urban Solutions, Mission Solutions, and Other segments. The Energy Solutions segment provides solutions to the energy transition markets, including asset decarbonization, carbon capture, renewable fuels, waste-to-energy, green chemicals, hydrogen, nuclear power, and other low-carbon energy sources. It also provides consulting services, including feasibility studies, process assessments, and project finance structuring; and a range of services for small modular reactor technologies, conventional and advanced nuclear reactor technologies. This segment serves the production and fuels, chemicals, LNG, power markets, chemicals and petrochemical industries. The Urban Solutions segment offers EPC and project management services to the infrastructure, advanced technologies, life sciences, and mining and metals industries. This segment also provides staffing services to the company and third-party clients with technical, professional, and craft resources on a contract or permanent placement basis. The Mission Solutions segment offers technical solutions to the U.S. and other governments. It also delivers solutions for nuclear security and operation, nuclear waste management, and laboratory management; and operation and maintenance, logistics, EPC, and life support solutions for mission-critical facilities across U.S. military service organizations. This segment offers site management, environmental remediation, and decommissioning for nuclear remediation at governmental facilities, as well as services to commercial nuclear clients. Fluor Corporation was founded in 1912 and is headquartered in Irving, Texas.

Luminex NASDAQ:LMNX

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays. The company also provides xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism; ARIES system, a sample to answer real-time PCR platform; SYNCT data management software solutions; and ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 Assay, ARIES Flu A/B & RSV Assay, ARIES Group B Streptococcus Assay, ARIES Group A Strep Assay, ARIES Bordetella Assay, ARIES Norovirus Assay, ARIES C. difficile Assay, ARIES MRSA Assay, and SARS-CoV-2 Assay. In addition, it offers VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; VERIGENE test cartridges; Amnis FlowSight imaging flow cytometers; Amnis ImageStream Mark II imaging flow cytometers; Amnis CellStream for cell and particle analysis; Guava easyCyte benchtop flow cytometers; Muse cell analyzers; and IDEAS, an image analysis software. Luminex Corporation was founded in 1995 and is based in Austin, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time